207 related articles for article (PubMed ID: 35655105)
1. Development of Optimized Sumatriptan-Prochlorperazine Combined Orodispersible Films Without Disintegrant: in vitro, ex vivo and in vivo Characterization.
Javed S; Hussain A; Shah PA; Raza SA; Anwer UU; Shamim R; Rasool F; Hafiz MA; Bukhari NI
AAPS PharmSciTech; 2022 Jun; 23(5):156. PubMed ID: 35655105
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of sumatriptan succinate and prochlorperazine maleate in orodispersible films using two validated UV-spectroscopic methods.
Javed S; Hussain A; Akhtar Shah P; Ishtiaq S; Ali E; Abbas N; Bukhari NI
Pak J Pharm Sci; 2022 Jan; 35(1(Supplementary)):183-194. PubMed ID: 35228176
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial.
Di Monda V; Nicolodi M; Aloisio A; Del Bianco P; Fonzari M; Grazioli I; Uslenghi C; Vecchiet L; Sicuteri F
Headache; 2003 Sep; 43(8):835-44. PubMed ID: 12940804
[TBL] [Abstract][Full Text] [Related]
4. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and Characterization of Orodispersible Composite Film from Hydroxypropylmethyl Cellulose-Crosslinked Carboxymethyl Rice Starch.
Kittipongpatana OS; Trisopon K; Wattanaarsakit P; Kittipongpatana N
Membranes (Basel); 2022 Jun; 12(6):. PubMed ID: 35736301
[TBL] [Abstract][Full Text] [Related]
6. Development of Polyvinyl Alcohol/Polyethylene Glycol Copolymer-based Orodispersible Films Loaded with Entecavir: Formulation and In vitro Characterization.
Wei T; Zhou BY; Wu XH; Liu XA; Huo MW; Huang XX; Shi LZ; Shi LL; Cao QR
Curr Drug Deliv; 2023 Oct; ():. PubMed ID: 37929732
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and in vitro evaluation of a polyvinyl alcohol/sodium alginate based orodispersible film containing sildenafil citrate.
Shi LL; Xu WJ; Cao QR; Yang M; Cui JH
Pharmazie; 2014 May; 69(5):327-34. PubMed ID: 24855822
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of polyvinyl alcohol based fast dissolving oral strips of sumatriptan succinate and metoclopramide HCL.
Zaman M; Hassan R; Razzaq S; Mahmood A; Amjad MW; Raja MAG; Qaisar AA; Majeed A; Hanif M; Tahir RA
Sci Prog; 2020; 103(4):36850420964302. PubMed ID: 33151131
[TBL] [Abstract][Full Text] [Related]
9. Freeze drying: exploring potential in development of orodispersible tablets of sumatriptan succinate.
Gugulothu D; Desai P; Pandharipande P; Patravale V
Drug Dev Ind Pharm; 2015 Mar; 41(3):398-405. PubMed ID: 24384027
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department.
Kostic MA; Gutierrez FJ; Rieg TS; Moore TS; Gendron RT
Ann Emerg Med; 2010 Jul; 56(1):1-6. PubMed ID: 20045576
[TBL] [Abstract][Full Text] [Related]
11. The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model.
Ghelardini C; Galeotti N; Vivoli E; Grazioli I; Uslenghi C
J Headache Pain; 2009 Dec; 10(6):435-40. PubMed ID: 19756945
[TBL] [Abstract][Full Text] [Related]
12. Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.
Cupone IE; Dellera E; Marra F; Giori AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322282
[TBL] [Abstract][Full Text] [Related]
13. Formulation of sumatriptan succinate orodispersible tablets using chitosan and sodium starch glycolate for immediate migraine relief.
Sahar T; Farid Hasan SM; Ahmad SA; Bushra R; Rehman A; Noor R; Usman S; Razvi N; Hassan F
Pak J Pharm Sci; 2024 Jan; 37(1):115-121. PubMed ID: 38741407
[TBL] [Abstract][Full Text] [Related]
14. The Development of Eletriptan Hydrobromide Immediate Release Buccal Films Using Central Composite Rotatable Design: An In Vivo and In Vitro Approach.
Siddique W; Zaman M; Sarfraz RM; Butt MH; Rehman AU; Fassih N; Albadrani GM; Bayram R; Alfaifi MY; Abdel-Daim MM
Polymers (Basel); 2022 Sep; 14(19):. PubMed ID: 36235932
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study.
Sandrini G; Cerbo R; Del Bene E; Ferrari A; Genco S; Grazioli I; Martelletti P; Nappi G; Pinessi L; Sarchielli P; Tamburro P; Uslenghi C; Zanchin G
Int J Clin Pract; 2007 Aug; 61(8):1256-69. PubMed ID: 17627707
[TBL] [Abstract][Full Text] [Related]
16. Sumatriptan succinate sublingual fast dissolving thin films: formulation and in vitro/in vivo evaluation.
Tayel SA; El Nabarawi MA; Amin MM; Abou Ghaly MH
Pharm Dev Technol; 2016; 21(3):328-37. PubMed ID: 25597782
[TBL] [Abstract][Full Text] [Related]
17. Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine.
Ghelardini C; Galeotti N; Grazioli I; Uslenghi C
J Pain; 2004 Oct; 5(8):413-9. PubMed ID: 15501422
[TBL] [Abstract][Full Text] [Related]
18. New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate.
Salehi S; Boddohi S
Prog Biomater; 2017 Dec; 6(4):175-187. PubMed ID: 29110144
[TBL] [Abstract][Full Text] [Related]
19. EFFECT OF POLYMER AND PLASTICIZER ON THIN POLYMERIC BUCCAL FILMS OF MELOXICAM DESIGNED BY USING CENTRAL COMPOSITE ROTATABLE DESIGN.
Zaman M; Hanif M; Qaiser AA
Acta Pol Pharm; 2016 Sep; 73(5):1351-1360. PubMed ID: 29638075
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole.
Lee JH; Park C; Song IO; Lee BJ; Kang CY; Park JB
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
